TipRanks
Icon plc (MX:ICLRN)
:ICLRN
Mexico Market
ICLRN
Icon
RESEARCH TOOLSreports

Icon (ICLRN) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

ICLRN Analyst Ratings

Moderate Buy
13Ratings
Moderate Buy
7 Buy
6 Hold
0 Sell
Based on 13 analysts giving stock ratings to
Icon
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ICLRN Stock 12 Month Forecast

Average Price Target

$4,261.08
▲(130.33% Upside)
Based on 13 Wall Street analysts offering 12 month price targets for Icon in the last 3 months. The average price target is $4,261.08 with a high forecast of $5,060.42 and a low forecast of $3,304.38. The average price target represents a 130.33% change from the last price of $1,850.00.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1849":"$1,849","2652":"$2,652","3455":"$3,455","4258":"$4,258","5061":"$5,061"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":5060.422961640001,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$5.06K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":4261.07754357,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$4.26K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3304.38066525,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$3.30K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[1849,2652,3455,4258,5061],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2914.91,3079.9494585876923,3244.988917175385,3410.028375763077,3575.0678343507693,3740.107292938462,3905.146751526154,4070.1862101138463,4235.225668701539,4400.265127289231,4565.304585876924,4730.344044464616,4895.383503052308,{"y":5060.422961640001,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2914.91,3018.4613495053845,3122.012699010769,3225.564048516154,3329.115398021538,3432.666747526923,3536.2180970323075,3639.769446537692,3743.320796043077,3846.872145548461,3950.4234950538457,4053.9748445592304,4157.526194064615,{"y":4261.07754357,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,2914.91,2944.8692819423077,2974.8285638846155,3004.787845826923,3034.7471277692307,3064.7064097115385,3094.6656916538464,3124.6249735961537,3154.5842555384615,3184.5435374807694,3214.502819423077,3244.4621013653846,3274.4213833076924,{"y":3304.38066525,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":3014.04,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3014.04,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3014.04,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3014.04,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3080,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2590,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1850.28,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1850.28,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1969,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1969,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1969,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1850,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2914.91,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$5,060Average Price Target$4,261Lowest Price Target$3,304
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
J.P. Morgan Analyst forecast on MX:ICLRN
Casey Woodring
J.P. Morgan
J.P. Morgan
$3,115.56→$3,776.44
Hold
104.13%
Upside
Reiterated
10/29/26
J.P. Morgan Sticks to Its Hold Rating for Icon (ICLR)
Robert W. Baird Analyst forecast on MX:ICLRN
Eric Coldwell
Robert W. Baird
Robert W. Baird
$3,965.26→$4,701.66
Buy
154.14%
Upside
Reiterated
10/29/26
Icon price target raised to $249 from $210 at BairdIcon price target raised to $249 from $210 at Baird
Citi Analyst forecast on MX:ICLRN
Patrick B Donnelly
Citi
Citi
$3,304.38→$4,059.67
Hold
119.44%
Upside
Reiterated
10/29/26
Icon price target raised to $215 from $175 at CitiIcon price target raised to $215 from $175 at Citi
TD Cowen Analyst forecast on MX:ICLRN
Charles Rhyee
TD Cowen
TD Cowen
$3,719.79→$4,796.07
Buy
159.25%
Upside
Reiterated
10/29/26
TD Cowen Keeps Their Buy Rating on Icon (ICLR)
Leerink Partners Analyst forecast on MX:ICLRN
Michael Cherny
Leerink Partners
Leerink Partners
$3,512.08→$4,154.08
Hold
124.54%
Upside
Reiterated
10/29/26
Leerink Partners Sticks to Their Hold Rating for Icon (ICLR)
UBS Analyst forecast on MX:ICLRN
Kevin Caliendo
UBS
UBS
$3,682.02→$4,456.19
Hold
140.88%
Upside
Assigned
10/29/26
UBS Keeps Their Hold Rating on Icon (ICLR)
Deutsche Bank Analyst forecast on MX:ICLRN
Justin Bowers
Deutsche Bank
Deutsche Bank
$3,776.44→$4,720.54
Buy
155.16%
Upside
Reiterated
10/29/26
Icon price target raised to $250 from $200 at Deutsche BankIcon price target raised to $250 from $200 at Deutsche Bank
Truist Financial Analyst forecast on MX:ICLRN
Jailendra Singh
Truist Financial
Truist Financial
$3,946.37→$5,060.42
Buy
173.54%
Upside
Reiterated
10/29/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Barclays Analyst forecast on MX:ICLRN
Luke Sergott
Barclays
Barclays
$3,304.38
Hold
78.62%
Upside
Reiterated
10/28/26
Analysts Offer Insights on Healthcare Companies: Icon (NASDAQ: ICLR), Centene (NYSE: CNC) and Gilead Sciences (NASDAQ: GILD)
RBC Capital Analyst forecast on MX:ICLRN
Ryan Halsted
RBC Capital
RBC Capital
$3,493.2→$4,267.37
Buy
130.67%
Upside
Assigned
10/28/26
Icon price target raised to $226 from $185 at RBC CapitalIcon price target raised to $226 from $185 at RBC Capital
Evercore ISI Analyst forecast on MX:ICLRN
Elizabeth Anderson CFA
Evercore ISI
Evercore ISI
$4,154.08→$3,398.79
Buy
83.72%
Upside
Reiterated
10/28/26
Analysts Are Bullish on Top Healthcare Stocks: Icon (ICLR), Beam Therapeutics (BEAM)
BMO Capital Analyst forecast on MX:ICLRN
Sean Dodge
BMO Capital
BMO Capital
$4,059.67→$4,437.31
Buy
139.85%
Upside
Assigned
10/28/26
Icon (ICLR) Gets a Buy from BMO Capital
Bank of America Securities Analyst forecast on MX:ICLRN
Lu Li
Bank of America Securities
Bank of America Securities
―
Hold
―
Upgraded
10/09/26
Icon upgraded to Neutral from Underperform at BofAIcon upgraded to Neutral from Underperform at BofA
William Blair Analyst forecast on MX:ICLRN
Jared Haase
William Blair
William Blair
―
Buy
―
Reiterated
07/29/26
Analysts' Top Healthcare Picks: Icon (ICLR), Biogen (BIIB)
Mizuho Securities Analyst forecast on MX:ICLRN
Ann Hynes
Mizuho Securities
Mizuho Securities
$3,398.79→$3,587.61
Buy
93.93%
Upside
Reiterated
06/26/26
Icon price target raised to $190 from $180 at MizuhoIcon price target raised to $190 from $180 at Mizuho
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
J.P. Morgan Analyst forecast on MX:ICLRN
Casey Woodring
J.P. Morgan
J.P. Morgan
$3,115.56→$3,776.44
Hold
104.13%
Upside
Reiterated
10/29/26
J.P. Morgan Sticks to Its Hold Rating for Icon (ICLR)
Robert W. Baird Analyst forecast on MX:ICLRN
Eric Coldwell
Robert W. Baird
Robert W. Baird
$3,965.26→$4,701.66
Buy
154.14%
Upside
Reiterated
10/29/26
Icon price target raised to $249 from $210 at BairdIcon price target raised to $249 from $210 at Baird
Citi Analyst forecast on MX:ICLRN
Patrick B Donnelly
Citi
Citi
$3,304.38→$4,059.67
Hold
119.44%
Upside
Reiterated
10/29/26
Icon price target raised to $215 from $175 at CitiIcon price target raised to $215 from $175 at Citi
TD Cowen Analyst forecast on MX:ICLRN
Charles Rhyee
TD Cowen
TD Cowen
$3,719.79→$4,796.07
Buy
159.25%
Upside
Reiterated
10/29/26
TD Cowen Keeps Their Buy Rating on Icon (ICLR)
Leerink Partners Analyst forecast on MX:ICLRN
Michael Cherny
Leerink Partners
Leerink Partners
$3,512.08→$4,154.08
Hold
124.54%
Upside
Reiterated
10/29/26
Leerink Partners Sticks to Their Hold Rating for Icon (ICLR)
UBS Analyst forecast on MX:ICLRN
Kevin Caliendo
UBS
UBS
$3,682.02→$4,456.19
Hold
140.88%
Upside
Assigned
10/29/26
UBS Keeps Their Hold Rating on Icon (ICLR)
Deutsche Bank Analyst forecast on MX:ICLRN
Justin Bowers
Deutsche Bank
Deutsche Bank
$3,776.44→$4,720.54
Buy
155.16%
Upside
Reiterated
10/29/26
Icon price target raised to $250 from $200 at Deutsche BankIcon price target raised to $250 from $200 at Deutsche Bank
Truist Financial Analyst forecast on MX:ICLRN
Jailendra Singh
Truist Financial
Truist Financial
$3,946.37→$5,060.42
Buy
173.54%
Upside
Reiterated
10/29/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Barclays Analyst forecast on MX:ICLRN
Luke Sergott
Barclays
Barclays
$3,304.38
Hold
78.62%
Upside
Reiterated
10/28/26
Analysts Offer Insights on Healthcare Companies: Icon (NASDAQ: ICLR), Centene (NYSE: CNC) and Gilead Sciences (NASDAQ: GILD)
RBC Capital Analyst forecast on MX:ICLRN
Ryan Halsted
RBC Capital
RBC Capital
$3,493.2→$4,267.37
Buy
130.67%
Upside
Assigned
10/28/26
Icon price target raised to $226 from $185 at RBC CapitalIcon price target raised to $226 from $185 at RBC Capital
Evercore ISI Analyst forecast on MX:ICLRN
Elizabeth Anderson CFA
Evercore ISI
Evercore ISI
$4,154.08→$3,398.79
Buy
83.72%
Upside
Reiterated
10/28/26
Analysts Are Bullish on Top Healthcare Stocks: Icon (ICLR), Beam Therapeutics (BEAM)
BMO Capital Analyst forecast on MX:ICLRN
Sean Dodge
BMO Capital
BMO Capital
$4,059.67→$4,437.31
Buy
139.85%
Upside
Assigned
10/28/26
Icon (ICLR) Gets a Buy from BMO Capital
Bank of America Securities Analyst forecast on MX:ICLRN
Lu Li
Bank of America Securities
Bank of America Securities
―
Hold
―
Upgraded
10/09/26
Icon upgraded to Neutral from Underperform at BofAIcon upgraded to Neutral from Underperform at BofA
William Blair Analyst forecast on MX:ICLRN
Jared Haase
William Blair
William Blair
―
Buy
―
Reiterated
07/29/26
Analysts' Top Healthcare Picks: Icon (ICLR), Biogen (BIIB)
Mizuho Securities Analyst forecast on MX:ICLRN
Ann Hynes
Mizuho Securities
Mizuho Securities
$3,398.79→$3,587.61
Buy
93.93%
Upside
Reiterated
06/26/26
Icon price target raised to $190 from $180 at MizuhoIcon price target raised to $190 from $180 at Mizuho
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
ARDXArdelyx
PVLAPalvella Therapeutics
CELCCelcuity
AMRXAmneal Pharmaceuticals
DNTHDianthus Therapeutics
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Icon

3 Months
David WindleyJefferies
Success Rate
27/43 ratings generated profit
63%
Average Return
+3.14%
Copying David Windley's trades and holding each position for 3 Months would result in 62.79% of your transactions generating a profit, with an average return of +3.14% per trade.
1 Year
David WindleyJefferies
Success Rate
26/43 ratings generated profit
60%
Average Return
+6.67%
Copying David Windley's trades and holding each position for 1 Year would result in 60.47% of your transactions generating a profit, with an average return of +6.67% per trade.
2 Years
Elizabeth Anderson CFAEvercore ISI
Success Rate
13/19 ratings generated profit
68%
Average Return
+4.09%
Copying Elizabeth Anderson CFA's trades and holding each position for 2 Years would result in 68.42% of your transactions generating a profit, with an average return of +4.09% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ICLRN Analyst Recommendation Trends

Rating
Jun 26
Jul 26
Aug 26
Sep 26
Oct 26
Strong Buy
1
0
0
0
0
Buy
16
21
16
8
11
Hold
15
14
6
3
11
Sell
3
4
3
1
0
Strong Sell
0
0
0
0
0
total
35
39
25
12
22
In the current month, ICLRN has received 11 Buy Ratings, 11 Hold Ratings, and 0 Sell Ratings. ICLRN average Analyst price target in the past 3 months is 4,261.08.
Each month's total comprises the sum of three months' worth of ratings.

ICLRN Financial Forecast

ICLRN Earnings Forecast

Next quarter’s earnings estimate for ICLRN is $53.40 with a range of $52.21 to $55.29. The previous quarter’s EPS was $50.23. ICLRN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year ICLRN has Performed in-line its overall industry.
Next quarter’s earnings estimate for ICLRN is $53.40 with a range of $52.21 to $55.29. The previous quarter’s EPS was $50.23. ICLRN beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year ICLRN has Performed in-line its overall industry.

ICLRN Sales Forecast

Next quarter’s sales forecast for ICLRN is $38.53B with a range of $38.26B to $39.10B. The previous quarter’s sales results were $38.23B. ICLRN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year ICLRN has Performed in-line its overall industry.
Next quarter’s sales forecast for ICLRN is $38.53B with a range of $38.26B to $39.10B. The previous quarter’s sales results were $38.23B. ICLRN beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year ICLRN has Performed in-line its overall industry.

ICLRN Stock Forecast FAQ

What is MX:ICLRN’s average 12-month price target, according to analysts?
Based on analyst ratings, Icon plc’s 12-month average price target is 4,261.08.
    What is MX:ICLRN’s upside potential, based on the analysts’ average price target?
    Icon plc has 130.33% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Icon plc a Buy, Sell or Hold?
          Icon plc has a consensus rating of Moderate Buy, which is based on 7 buy ratings, 6 hold ratings and 0 sell ratings.
            What is Icon plc’s share price target?
            The average share price target for Icon plc is 4,261.08. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is $5,060.42 ,and the lowest forecast is $3,304.38. The average share price target represents 130.33% Increase from the current price of $1,850.
              What do analysts say about Icon plc?
              Icon plc’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 13 Wall Streets Analysts.
                How can I buy shares of Icon plc?
                To buy shares of MX:ICLRN, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.